Company: CERO
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001213900-25-044335
Chunk: 328

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part II, Item 4
Chunk 328
---
, 2025
    By:
    /s/ Chris Ehrlich

    Name: 
    Chris Ehrlich

    Title:
    Interim Chairman and Chief Executive Officer

    (Principal Executive Officer)

    Date May 15, 2025
    By:
    /s/ Andrew Kucharchuk

    Name:
    Andrew Kucharchuk

    Title:
    Chief Financial Officer

    (Principal Financial and Accounting Officer)

44

P5Y
P5Y

30000
0001870404
false
Q1
--12-31

    0001870404

    2025-01-01
    2025-03-31

    0001870404
    
      cero:CommonStockParValue00001PerShareMember

    2025-01-01
    2025-03-31

    0001870404
    
      cero:WarrantsToPurchaseOneShareOfCommonStockMember

    2025-01-01
    2025-03-31

    0001870404

    2025-05-14

    0001870404

    2025-03-31

    0001870404

    2024-12-31

    0001870404
    
      cero:SeriesCConvertiblePreferredStockMember

    2025-03-31

    0001870404
    
      cero:SeriesCConvertiblePreferredStockMember

    2024-12-31

    0001870404
    
      cero:SeriesAConvertiblePreferredStockMember

    2025-03-31

    0001870404
    
      cero:SeriesAConvertiblePreferredStockMember

    2024-12-31

    0001870404
    
      cero:SeriesBConvertiblePreferredStockMember

    2025-03-31

    0001870404
    
      cero:SeriesBConvertiblePreferredStockMember

    2024-12-31

    0001870404
    
      us-gaap:CommonClassAMember

    2025-03-31

    0001870404
    
      us-gaap:CommonClassAMember

    2024-12-31

    0001870404

    2024-02-14
    2024-03